{
    "SPADE_UN_25845": {
        "Sequence Information": {
            "Peptide Name": "Crabrolin [L4R;T11R]",
            "Sequence": "FLPRILRKIVRAL",
            "Sequence Length": 13,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell",
                "Antibiofilm"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P01518",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P01518",
                    "description": "The amino acid sequence of the current peptide coincides with the amino acid sequence of the UniProt entry."
                }
            ],
            "Literature": [
                {
                    "Title": "A Designed Analog of an Antimicrobial Peptide, Crabrolin, Exhibits Enhanced Anti-Proliferative and In Vivo Antimicrobial Activity.",
                    "Pubmed ID": "37833918",
                    "Reference": "Int J Mol Sci. 2023;24:14472",
                    "Author": "Yao A, Ma Y, Sun R, Zou W, Chen X, Zhou M, Ma C, Chen T, Shaw C, Wang L",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/37833918"
                }
            ],
            "Mass": 1595.03,
            "PI": 12.0,
            "Net Charge": 4,
            "Hydrophobicity": 0.78,
            "Frequent Amino Acids": "LRI",
            "Absent Amino Acids": "CDEGHMNOQSTUWY",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 8,
            "Polar Residues": 5,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_25845",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_11520",
                    "Similarity": 1.0,
                    "Sequence": "FVPWFSKFLPRIL"
                },
                {
                    "SPADE_ID": "SPADE_UN_14146",
                    "Similarity": 1.0,
                    "Sequence": "FVPWFSKFLPRIL"
                },
                {
                    "SPADE_ID": "SPADE_UN_14147",
                    "Similarity": 1.0,
                    "Sequence": "FVPWFSKFLPRIL"
                }
            ],
            "Hemolytic Activity": "Horse erythrocytes:10% Hemolysis=36.041 µM,Horse erythrocytes:50% Hemolysis=211.927 µM,Human keratinocytes HaCat:IC50=20.85 µM,Human microvascular endothelial cells HMEC-1:37% Cytotoxicity=100 µM",
            "Target Organism": "Staphylococcus aureus NCTC 10788(MIC=1µM),Staphylococcus aureus NCTC 10788(MBC=2µM),Escherichia coli ATCC 8739(MIC=2µM),Escherichia coli ATCC 8739(MBC=4µM),Staphylococcus aureus NCTC 12493(MIC=2µM),Staphylococcus aureus NCTC 12493(MBC=2µM),Klebsiella pneumoniae ATCC 43816(MIC=8µM),Klebsiella pneumoniae ATCC 43816(MBC=8µM),Enterococcus faecium NTCC 12697(MIC=4µM),Enterococcus faecium NTCC 12697(MBC=8µM),Pseudomonas aeruginosa ATCC 9027(MIC=4µM),Pseudomonas aeruginosa ATCC 9027(MBC=8µM),Human lung adenocarcinoma NCI-H838(IC50=5.637µM),Human prostate adenocarcinoma PC-3(IC50=3.944µM),Human glioblastoma U251-MG(IC50=12.4µM),Human colon adenocarcinoma HCT 116(IC50=2.81µM),Human breast adenocarcinoma MCF-7(IC50=3.459µM)"
        }
    }
}